Fractyl Health (GUTS) announced the pricing of an underwritten offering of 60 million shares of its common stock at a price of $1.00 per share. All of the securities are being offered by Fractyl. The gross proceeds from the offering to Fractyl are expected to be approximately $60 million, before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about September 29, 2025, subject to customary closing conditions. BofA Securities and Evercore ISI are acting as joint book-running managers and Ladenburg Thalmann is acting as lead manager for the underwritten offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GUTS:
- Fractyl Health announces REMAIN-1 study met 3-month efficacy endpoint
- Fractyl Health initiated with a Buy at H.C. Wainwright
- Fractyl Health Appoints New Directors Amid Leadership Changes
- Fractyl Health appoints Christopher Thompson, Ian Sheffield to board
- Fractyl Health initiated with a Buy at Ladenburg